These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29150154)

  • 1. Cutaneous squamous cell carcinomas (SCC) associated with cosmetic skin whitening: 8 cases reported in Senegal.
    Ly F; Diousse P; Ndiaye C; Déme A; Diatta BA; Ndiaye MT; Diallo M; Diop A; Kebe AD; Fall F; Kane A
    Ann Dermatol Venereol; 2018 Feb; 145(2):83-88. PubMed ID: 29150154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Squamous cell carcinoma associated with use of skin-lightening cream].
    Faye O; Dicko AA; Berthé S; Cissé L; Traoré B; Keita A; Fofana Y; Coulibaly K; Keita B
    Ann Dermatol Venereol; 2018 Feb; 145(2):100-103. PubMed ID: 28800923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [First cases of squamous cell carcinoma associated with cosmetic use of bleaching compounds].
    Ly F; Kane A; Déme A; Ngom NF; Niang SO; Bello R; Rethers L; Dangou JM; Dieng MT; Diousse P; Ndiaye B
    Ann Dermatol Venereol; 2010 Feb; 137(2):128-31. PubMed ID: 20171436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aesthetic problems associated with the cosmetic use of bleaching products.
    Ly F; Soko AS; Dione DA; Niang SO; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Int J Dermatol; 2007 Oct; 46 Suppl 1():15-7. PubMed ID: 17919199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal.
    Mahé A; Ly F; Aymard G; Dangou JM
    Br J Dermatol; 2003 Mar; 148(3):493-500. PubMed ID: 12653741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of suspected illegal skin whitening cosmetics.
    Desmedt B; Van Hoeck E; Rogiers V; Courselle P; De Beer JO; De Paepe K; Deconinck E
    J Pharm Biomed Anal; 2014 Mar; 90():85-91. PubMed ID: 24334193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mercury, hydroquinone and clobetasol propionate in skin lightening products in West Africa and Canada.
    Gbetoh MH; Amyot M
    Environ Res; 2016 Oct; 150():403-410. PubMed ID: 27372064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Challenges posed by cosmetic skin-bleaching].
    Mahé A
    Ann Dermatol Venereol; 2018 Feb; 145(2):81-82. PubMed ID: 29221653
    [No Abstract]   [Full Text] [Related]  

  • 9. [Economic impact of skin-lightening products on household income in sub-Saharan Africa: the case of Senegal].
    Diongue M; Ndiaye P; Douzima PM; Seck M; Seck I; Faye A; Diagne MC; Leye MM; Niang K; Tal AD
    Med Sante Trop; 2013; 23(3):308-12. PubMed ID: 24026056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic complications during voluntary cosmetic depigmentation among women in Togo: A case-control study.
    Akakpo AS; Mouhari-Toure A; Saka B; Téclessou J; Kombaté K; Tchangaï-Walla K; Pitché P
    Ann Dermatol Venereol; 2016 Mar; 143(3):197-201. PubMed ID: 26783177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics and risk factors for recurrence of cutaneous squamous cell carcinoma with conventional surgery and surgery with delayed intraoperative margin assessment].
    Domínguez-Cherit J; Rodríguez-Gutiérrez G; Narváez Rosales V; Toussaint Caire S; Fonte Avalos V
    Cir Cir; 2017; 85(6):499-503. PubMed ID: 28087048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Skin lightening products are a part of everyday life in many parts of the world. Corticosteroids, hydroquinone and mercury are common ingredients].
    Wallander M; Löfgren P; Rydén M
    Lakartidningen; 2015 Jun; 112():. PubMed ID: 26126005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicology and carcinogenesis studies of pyrogallol (CAS No. 87-66-1) in F344/N rats and B6C3F1/N mice (dermal studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Feb; (574):1-167. PubMed ID: 23518671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular lesions of artificial depigmentation].
    Ndoye Roth PA; Ly F; Kane H; Bissang AA; Wane AM; Sow AS; Ndiaye JM; Nguer M; Ba EA; Ndiaye MR
    J Fr Ophtalmol; 2015 Jun; 38(6):493-6. PubMed ID: 25957518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
    Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
    Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous Cell Carcinoma Associated with Cosmetic Use of Bleaching Agents: About a Case in Ivory Coast.
    Gbandama KKP; Diabaté A; Kouassi KA; Kouassi YI; Allou AS; Kaloga M
    Case Rep Dermatol; 2019; 11(3):322-326. PubMed ID: 31911770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of potentially harmful skin-lightening products among immigrant women in Rome, Italy: a pilot study.
    Cristaudo A; D'Ilio S; Gallinella B; Mosca A; Majorani C; Violante N; Senofonte O; Morrone A; Petrucci F
    Dermatology; 2013; 226(3):200-6. PubMed ID: 23751225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cosmetic skin lightening use and side effects.
    Masub N; Khachemoune A
    J Dermatolog Treat; 2022 May; 33(3):1287-1292. PubMed ID: 33135510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous ochronosis: the failure of depigmenting creams.
    Sánchez-Martínez EM; García-Briz MI; Moneva-Léniz LM; Gegúndez-Hernández H; Pose-Lapausa P; Mateu-Puchades A
    Dermatol Online J; 2019 Apr; 25(4):. PubMed ID: 31046915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.